BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15528025)

  • 1. Identification of high-risk pancreatic cancer-prone families.
    Brand RE; Lynch HT
    Gastroenterol Clin North Am; 2004 Dec; 33(4):907-18. PubMed ID: 15528025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary pancreatic cancer: a clinical perspective.
    Greer JB; Lynch HT; Brand RE
    Best Pract Res Clin Gastroenterol; 2009; 23(2):159-70. PubMed ID: 19414143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype/phenotype of familial pancreatic cancer.
    Brand RE; Lynch HT
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):405-15, xi. PubMed ID: 16632102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial pancreatic cancer syndromes.
    Habbe N; Langer P; Sina-Frey M; Bartsch DK
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International registries of families at high risk of pancreatic cancer.
    Greenhalf W; Malats N; Nilsson M; Bartsch D; Neoptolemos J
    Pancreatology; 2008; 8(6):558-65. PubMed ID: 18818508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenging pancreatic cancer-prone pedigrees: a nosologic dilemma.
    Lynch HT; Deters CA; Lynch JF; Brand RA
    Am J Gastroenterol; 2002 Dec; 97(12):3062-70. PubMed ID: 12492191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary factors in pancreatic cancer.
    Lynch HT; Brand RE; Lynch JF; Fusaro RM; Kern SE
    J Hepatobiliary Pancreat Surg; 2002; 9(1):12-31. PubMed ID: 12021894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.
    Lynch HT; Deters CA; Snyder CL; Lynch JF; Villeneuve P; Silberstein J; Martin H; Narod SA; Brand RE
    Cancer Genet Cytogenet; 2005 Apr; 158(2):119-25. PubMed ID: 15796958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for cancer susceptibility genes in children.
    Laxova R
    Adv Pediatr; 1999; 46():1-40. PubMed ID: 10645460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary ovarian cancer.
    Prat J; Ribé A; Gallardo A
    Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary pancreatic cancer.
    Lynch HT; Brand RE; Deters CA; Shaw TG; Lynch JF
    Pancreatology; 2001; 1(5):466-71. PubMed ID: 12120226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
    Brunsvold AN; Wung SF; Merkle CJ
    J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial pancreatic cancer].
    Zalatnai A
    Magy Onkol; 2006; 50(2):163-8. PubMed ID: 16888680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Indirect' BRCA1/2 testing: a useful approach in hereditary breast and ovarian cancer families without a living affected relative.
    Cruger DG; Kruse TA; Gerdes AM
    Clin Genet; 2005 Sep; 68(3):228-33. PubMed ID: 16098011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial pancreatic cancer: from genes to improved patient care.
    Hruban RH; Klein AP; Eshleman JR; Axilbund JE; Goggins M
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):81-8. PubMed ID: 19072437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature.
    Ghataorhe P; Kurian AW; Pickart A; Trapane P; Norton JA; Kingham K; Ford JM
    Cancer Genet Cytogenet; 2007 Dec; 179(2):89-92. PubMed ID: 18036394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.